Auvo Antero Juhani Kaikkonen

Inion Oy is a medical devices company focused on the development and commercialization of innovative biodegradable and bioactive implants for applications in Spine and Specialty Orthopedics applications. By targeting key strategic markets in the USA and select territories in the rest of the world, Inion has built a product portfolio sold through a dedicated network of specialist distributors. Inion's products include biodegradable plates, screws, pins and membranes, which are used to enhance the healing of bone or soft tissue injuries, such as those caused by trauma or by reconstructive surgery. Inion's core expertise is in the design and manufacture of implants from its proprietary Inion Optima™ family of biomaterials, which enables the Company to develop medical implants with properties tailored for specific surgical applications, in terms of strength, flexibility and rate of degradation. Incorporated in 2000, Inion has offices in the UK and USA, and its head office, R&D and manufacturing facilities are in Tampere, Finland.

EpiCrystals Oy develops semiconductor lasers for projection screen applications. Its patented decibel laser platform enables fabrication of novel ultra-compact and cost-efficient projectors with superior image quality. The firm’s products include green and rgb lasers which are designed to be used as light source in laser projection applications. The company was founded by Tomi Pekka Jouhti and Janne Konttinen in 2003 and is headquartered in Tampere, Finland.

Plexpress offers high-content gene expression analysis for cell biology research, enabling higher throughput and providing more information than competitors' products. Plexpress analysis service is a cost and time efficient solution for large screens in preclinical drug discovery studies, safety assays and yeast studies. Plexpress was established as a spinoff from the Finnish Technology Research Center VTT in 2007. Including R&D at VTT, the company's TRAC technology has been developed continuously for nearly 10 years and it has been documented in over 15 publications. The technology was originally developed for demanding bioprocess applications, which required a very robust solution for gene expression analysis. The principal developers of the technology, Hans Soderlund and Jari Rautio, are still closely involved with the company as Chairman of the Scientific Advisory Board and VP of R&D, respectively. Since starting operations in 2008, the company has carried out projects using the TRAC technology in the fields of pharmaceutical development and academic research.

Ozics Oy develops materials and implants for mending bones in case of fractures. It also provides surgical appliances for surgeries treatments. The company was founded by Auvo A. Kaikkonen in 2008 and is headquartered in Tampere, Finland.

Ozics Holdings Ltd. is a sales and marketing company. The company operates under Ozics OY, a Finland based corporation, for the purpose of commercializing a proprietary, unique bone cement technology used in orthopedic surgery. The cement promotes greater stability, decreases healing time and augments the efficacy of standard orthopedic hardware used to hold bones together. Ozics Holdings is headquartered in Hamilton, Bermuda.

Bio Bones Oy provides mechanical engineering services. The private company is based in Oulu, Finland.